Bristol-Myers Changes DTC Ad Policy

Join us at Brandweek Sept. 12–16 in Miami alongside leading CMOs, founders and change makers from GatoradeMarriottAlo YogaCampbell'sUncommon James and more. Book now.

BOSTON Bristol-Myers Squibb said it would cease advertising drugs directly to consumers during their first year on the market.

The client spent $140 million on paid media in 2004, per Nielsen Monitor-Plus.

“For a minimum of 12 months following a launch of a new medication, Bristol-Myers Squibb will refrain from any direct-to-consumer branded mass media [television, radio and print] advertising to promote the medication,” the client said in a “DTC Communications Code” posted on its Web site.

AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in